These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 17177140)
1. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Hahn S; Haselhorst U; Tan S; Quadbeck B; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):577-83. PubMed ID: 17177140 [TBL] [Abstract][Full Text] [Related]
2. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance. Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987 [TBL] [Abstract][Full Text] [Related]
3. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Yildizhan R; Kurdoglu M; Adali E; Kolusari A; Yildizhan B; Sahin HG; Kamaci M Arch Gynecol Obstet; 2009 Oct; 280(4):559-63. PubMed ID: 19214546 [TBL] [Abstract][Full Text] [Related]
4. Serum Vitamin D Binding Protein Level Associated with Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome. Kuliczkowska-Plaksej J; Pasquali R; Milewicz A; Lwow F; Jedrzejuk D; Bolanowski M Horm Metab Res; 2019 Jan; 51(1):54-61. PubMed ID: 30408832 [TBL] [Abstract][Full Text] [Related]
5. 25(OH) vitamin D levels in premenopausal women with polycystic ovary syndrome and/or obesity. Tsakova AD; Gateva AT; Kamenov ZA Int J Vitam Nutr Res; 2012 Dec; 82(6):399-404. PubMed ID: 23823925 [TBL] [Abstract][Full Text] [Related]
6. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome. Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China. Wang L; Lv S; Li F; Yu X; Bai E; Yang X Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394 [No Abstract] [Full Text] [Related]
8. Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome. Velija-Ašimi Z Med Glas (Zenica); 2014 Feb; 11(1):170-6. PubMed ID: 24496360 [TBL] [Abstract][Full Text] [Related]
9. Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism. Hahn S; Backhaus M; Broecker-Preuss M; Tan S; Dietz T; Kimmig R; Schmidt M; Mann K; Janssen OE Eur J Endocrinol; 2007 Aug; 157(2):201-7. PubMed ID: 17656599 [TBL] [Abstract][Full Text] [Related]
10. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842 [TBL] [Abstract][Full Text] [Related]
11. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650 [TBL] [Abstract][Full Text] [Related]
12. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Mahmoudi T; Gourabi H; Ashrafi M; Yazdi RS; Ezabadi Z Fertil Steril; 2010 Mar; 93(4):1208-14. PubMed ID: 19230880 [TBL] [Abstract][Full Text] [Related]
13. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Panidis D; Balaris C; Farmakiotis D; Rousso D; Kourtis A; Balaris V; Katsikis I; Zournatzi V; Diamanti-Kandarakis E Clin Chem; 2005 Sep; 51(9):1691-7. PubMed ID: 16037412 [TBL] [Abstract][Full Text] [Related]
14. 25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome. Güdücü N; Görmüş U; Kutay SS; Kavak ZN; Dünder I Gynecol Endocrinol; 2014 Aug; 30(8):557-60. PubMed ID: 24819314 [TBL] [Abstract][Full Text] [Related]
15. Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome. Sahin FK; Sahin SB; Ural UM; Cure MC; Senturk S; Tekin YB; Balik G; Cure E; Yuce S; Kirbas A Bosn J Basic Med Sci; 2015 Jul; 15(3):57-63. PubMed ID: 26295295 [TBL] [Abstract][Full Text] [Related]
16. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649 [TBL] [Abstract][Full Text] [Related]
17. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Pehlivanov B; Mitkov M Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711 [TBL] [Abstract][Full Text] [Related]
18. White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia. Papalou O; Livadas S; Karachalios A; Tolia N; Kokkoris P; Tripolitakis K; Diamanti-Kandarakis E Hormones (Athens); 2015; 14(1):91-100. PubMed ID: 25553762 [TBL] [Abstract][Full Text] [Related]
19. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. Laughlin GA; Morales AJ; Yen SS J Clin Endocrinol Metab; 1997 Jun; 82(6):1692-6. PubMed ID: 9177365 [TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome. Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]